Dr Forrester reiterated Dr Dow in stating that the cost to benefit ratio of introducing surrogate screening in the West of Scotland means he would recommend against it.
Chronology Information
Date:
Chapter/issue
Hepatitis C Surrogate Screening
Key Person(s)
Dr John M Forrester
Dr Brian Charles Dow